Get the Stockscreener App
3.37
1.20%
0.04
Co Diagnostics Inc stock is traded at $3.37, with a volume of 615.70K.
It is up +1.20% in the last 24 hours and up +145.99% over the past month.
Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
See More
Previous Close:
$3.33
Open:
$3.26
24h Volume:
615.70K
Relative Volume:
0.10
Market Cap:
$12.42M
Revenue:
$513.90K
Net Income/Loss:
$-48.50M
P/E Ratio:
-0.1203
EPS:
-28.0101
Net Cash Flow:
$-28.99M
1W Performance:
-28.30%
1M Performance:
+145.99%
6M Performance:
-64.22%
1Y Performance:
-87.42%
1-Day Range:
$3.10
$3.44
1-Week Range:
$2.95
$4.98
52-Week Range:
$1.26
$13.54
Co Diagnostics Inc Stock (CODX) Company Profile
Name
Co Diagnostics Inc
Sector
Industry
Phone
(801) 438-1036
Address
2401 S FOOTHILL DRIVE, SALT LAKE CITY
Compare CODX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
3.37 | 12.42M | 513.90K | -48.50M | -28.99M | -28.01 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-22 | Downgrade | Sidoti | Buy → Neutral |
| Dec-29-21 | Initiated | Sidoti | Buy |
| Mar-29-21 | Downgrade | Maxim Group | Buy → Hold |
| May-20-20 | Upgrade | Maxim Group | Hold → Buy |
| May-18-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-09-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-03-20 | Downgrade | Maxim Group | Buy → Hold |
View All
Co Diagnostics Inc Stock (CODX) Latest News
Co-Diagnostics, Inc. and Comira Diagnostics Host Unveiling of Future Automated Manufacturing Line - marketscreener.com
Co-Diagnostics hosts Saudi joint venture for manufacturing tour - Investing.com
Saudi JV tours Co-Diagnostics site ahead of tech transfer - Stock Titan
Co-Diagnostics Inc (CODX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Co-Diagnostics Inc (CODX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Co-Diagnostics Inc (CODX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Co-Diagnostics Inc (CODX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Co-Diagnostics Inc (CODX) Institutional Confidence - TradingKey
CODX Stock Price, Quote & Chart - ChartMill
Co-Diagnostics Signs Exclusive Distribution Deal With Mexican Partner; Shares Rise Pre-Bell - Moomoo
Co-Diagnostics develops Ebola assay strategy following WHO emergency alert (CODX) - MSN
Co-Diagnostics (CODX) Expands Distribution Agreement in Mexico - GuruFocus
Co-Diagnostics signs exclusive Mexico distribution deal - Investing.com UK
Co-Diagnostics signs exclusive Mexico distribution deal By Investing.com - Investing.com South Africa
Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ PCR Pro® with Mexico Distributor Agreement - PR Newswire
Co-diagnostics Company Profile & Introduction - Moomoo
Co-Diagnostics Advances Latin American Commercialization Strateg - GuruFocus
CODX Q1 2026 Earnings: EPS Falls Short of Estimates as Company Continues Strategic PivotDividend Increase Stocks - newsline.com
Co-diagnostics(CODX) Stock Options Chain | Quotes & News - Moomoo
CODX Q1 2026 Earnings: Wider-than-Expected Loss as Revenue Remains NilQuarterly Earnings - newsline.com
OpenAI's Major Overhaul: Aiming for Growth Before IPO - GuruFocus
Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C. - Eastern Progress
symbol__ Stock Quote Price and Forecast - CNN
Jane Street Group, LLC's Strategic Acquisition of Co-Diagnostics Inc Shares - GuruFocus
Jane Street entities report 6.4% stake in Co-Diagnostics (CODX) - Stock Titan
Co-Diagnostics (CODX) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
Co-Diagnostics advances Ebola PCR test development program - Investing.com UK
Co-Diagnostics (CODX) Advances Ebola PCR Development Program - GuruFocus
Co-Diagnostics advances Ebola PCR test development program By Investing.com - Investing.com South Africa
Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities - StreetInsider
Q4 2025 Co-Diagnostics Inc Earnings Call Transcript - GuruFocus
Q1 2026 Co-Diagnostics Inc Earnings Call Transcript - GuruFocus
[EFFECT] Co-Diagnostics, Inc. SEC Filing - Stock Titan
Is Co-Diagnostics National Security's next diagnostic pick? - MSN
CODX - Finviz
$Co-diagnostics (CODX.US)$ Fuhh... - Moomoo
Co-Diagnostics: Offering Expected to Close on or About May 21 >CODX - Moomoo
Co-Diagnostics (CODX) registers 4.94M shares for resale; up to $5.18M possible - Stock Titan
Is Co-Diagnostics National Security’s Next Diagnostic Pick? - Investing.com
Is Co-Diagnostics National Security’s Next Diagnostic Pick? - MarketBeat
$Co-diagnostics (CODX.US)$ more the boyzzz want - Moomoo
Co-Diagnostics (CODX) Q4 2025 Earnings Transcript - AOL.com
Co-Diagnostics (NASDAQ: CODX) CEO nets RSU shares after tax sale - Stock Titan
Co-Diagnostics (NASDAQ: CODX) CFO reports RSU vesting and tax-related share sale - Stock Titan
Co Diagnostics Inc Stock (CODX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):